Translate Bio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch Translate Bio and buy or sell other stocks, options, and ETFs commission-free!

About TBIO

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. 

CEO
Ronald C. Renaud, Jr., MBA
CEORonald C. Renaud, Jr., MBA
Employees
Employees
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2011
Founded2011
Employees
Employees

TBIO Key Statistics

Market cap
2.82B
Market cap2.82B
Price-Earnings ratio
74.36
Price-Earnings ratio74.36
Dividend yield
Dividend yield
Average volume
1.07M
Average volume1.07M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$37.99
52 Week high$37.99
52 Week low
$11.91
52 Week low$11.91

TBIO Earnings

-$0.28
-$0.07
$0.13
$0.34
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
per share
Estimated per share
Actual
Expected Feb 24, Pre-Market
ActualExpected Feb 24, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.